United Guardian UG
NASDAQ UG
$7.11 -0.01 (-0.14%)
As of: Sep 9, 2026 · 12:33 PM EDT

United Guardian (UG) Liabilities and Shareholders Equity (2010 - 2026)

United Guardian's (UG) quarterly Liabilities and Shareholders Equity came in at $13.6 million in Q2 2026, up 1.48% year-over-year from $13.4 million in Q2 2025, and up 7.03% quarter-over-quarter from $12.7 million in Q1 2026.

Analysis

United Guardian (UG) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

United Guardian has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $13.6 million for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity rose 1.48% year-over-year to $13.6 million; the TTM figure through Jun 2026 stood at $51.6 million (down 3.06% YoY), while the FY2025 annual figure was $13.1 million, down 4.99% from the prior year.
  • Liabilities and Shareholders Equity came in at $13.6 million for Q2 2026 at United Guardian, up from $12.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $13.8 million in Q2 2024 to a low of $10.6 million in Q4 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $12.6 million, with a median of $12.8 million recorded in 2023.
  • Year-over-year, Liabilities and Shareholders Equity slipped 14.31% in 2022 and advanced 21.45% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $10.6 million in 2022, then grew by 21.45% to $12.9 million in 2023, then grew by 6.77% to $13.8 million in 2024, then retreated by 4.99% to $13.1 million in 2025, then grew by 3.69% to $13.6 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $13.6 million in Q2 2026, $12.7 million in Q1 2026, and $13.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 643.84 Bn 623.08 Bn 17.26 Bn 201.06 Bn
2 AbbVie 441.33 Bn 434.76 Bn 12.70 Bn 135.12 Bn
3 Merck 364.84 Bn 357.70 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 266.34 Bn 258.65 Bn 11.24 Bn 122.03 Bn
5 Pfizer 159.07 Bn 147.37 Bn 10.94 Bn 201.13 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn 150.01 Bn
7 Revolution Medicines 44.22 Bn 44.22 Bn - 4.32 Bn
8 Incyte 25.24 Bn 20.70 Bn 1.57 Bn 7.87 Bn
9 United Therapeutics 21.42 Bn 18.76 Bn 683.80 Mn 7.22 Bn
10 United Guardian 32.67 Mn 23.07 Mn 1.55 Mn 13.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.59 Mn
Mar 31, 2026 12.70 Mn
Dec 31, 2025 13.11 Mn
Sep 30, 2025 12.18 Mn
Jun 30, 2025 13.39 Mn
Mar 31, 2025 12.76 Mn
Dec 31, 2024 13.80 Mn
Sep 30, 2024 13.25 Mn
Jun 30, 2024 13.83 Mn
Mar 31, 2024 13.05 Mn
Dec 31, 2023 12.92 Mn
Sep 30, 2023 12.17 Mn
Jun 30, 2023 11.88 Mn
Mar 31, 2023 11.94 Mn
Dec 31, 2022 10.64 Mn
Sep 30, 2022 11.68 Mn
Jun 30, 2022 11.68 Mn
Mar 31, 2022 12.94 Mn
Dec 31, 2021 12.24 Mn
Sep 30, 2021 13.63 Mn